Insider Trading Activity For Mentor Capital Inc (NASDAQ:MNTR)
Chester Billingsley , CEO of Mentor Capital Inc (NASDAQ:MNTR) reportedly Sold 8,584 shares of the company’s stock at an average price of 0.7 for a total transaction amount of $6,008.80 SEC Form
Analyst Ratings For Mentor Capital Inc (NASDAQ:MNTR)
These are No ratings tracked in the last 12 months.The current consensus rating for Mentor Capital Inc (NASDAQ:MNTR) is N/A (Score: NaN) with a consensus target price of N/A
About Mentor Capital Inc (NASDAQ:MNTR)
Mentor Capital Inc is a United States-based firm that invests in medical marijuana and recreational use cannabis companies. The Firm has $140 million capital structure and looks like a marijuana fund or cannabis index fund. Its preferred focus is medical and the Company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma and blunting chronic pain. Its portfolio includes Agenus, Inc, Brighter Day Health, CannaVest, Cel Sci Corp, TBA, Pfizer, Inc, Vical and WCI INC, among others. Effective March 11, 2014, Mentor Capital Inc acquired a 60% interest in Bhang Chocolate Co Inc, a producer of medicated chocolate bars.
Recent Trading Activity for Mentor Capital Inc (NASDAQ:MNTR)
Shares of Mentor Capital Inc closed the previous trading session at 0.640 down -0.009 -1.45% with 223,726 shares trading hands.
